Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy.

MLA

Decker, Corinne E., et al. “Genome-Scale CRISPR Activation Screen Uncovers Tumor-Intrinsic Modulators of CD3 Bispecific Antibody Efficacy.” Scientific Reports, vol. 9, no. 1, Dec. 2019, p. 20068. EBSCOhost, https://doi.org/10.1038/s41598-019-56670-x.

APA

Decker, C. E., Young, T., Pasnikowski, E., Chiu, J., Song, H., Wei, Y., Thurston, G., & Daly, C. (2019). Genome-scale CRISPR activation screen uncovers tumor-intrinsic modulators of CD3 bispecific antibody efficacy. Scientific Reports, 9(1), 20068. https://doi.org/10.1038/s41598-019-56670-x

Chicago

Decker, Corinne E, Tara Young, Elizabeth Pasnikowski, Joyce Chiu, Hang Song, Yi Wei, Gavin Thurston, and Christopher Daly. 2019. “Genome-Scale CRISPR Activation Screen Uncovers Tumor-Intrinsic Modulators of CD3 Bispecific Antibody Efficacy.” Scientific Reports 9 (1): 20068. doi:10.1038/s41598-019-56670-x.